1Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
6Gottlieb S,Fisher ML,Kjekshus J,on behalf of the MERIT-HF Investigators.Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).Circulation,2002,105:1182-1188.
7Macdonald PS,KeoghAM,Aboyoun CL,et al.Tolerability and efficacy of carvedilol in patients with New York Heart Association class Ⅳ heart failure.J Am Coll Cardiol,1999,33:924-931.
8Waagstein F,Bristow MR,Swedberg K,et al.Beneficial effects of metoprolol in idiopathicdilated cardiomyopathy.Lancet,1993,342:1441-1446.
9Engelmeier RS,O'Connell JB,Walsh R,et al.Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy:a double-blind,randomized,placebocontrolled trial.Circulation,1985,72:536-546.
10Fisher ML,Gottlieb SS,Plotnick GD,et al.Beneficial effects of metoprolol in heart failure associated with coronary artery disease:a randomized trial.J Am Coll Cardiol,1994,23:943-950.
